Literature DB >> 25753966

Evaluation of VTE Prophylaxis in an Educational Hospital: Comparison Between the Institutional Guideline (Caprini 2006) and the ACCP Guideline (Ninth Edition).

Lubna Gharaibeh1, Abla Albsoul-Younes2, Nidal Younes3.   

Abstract

Venous thromboembolism (VTE) is the most common preventable cause of hospital death; the burden of VTE includes the management of the acute event (deep vein thrombosis [DVT]/pulmonary embolism) and the chronic subsequents such as postthrombotic syndrome and recurrent DVT. All experts agree that despite the abundance of knowledge available on VTE and how to prevent it, it is still underused, and since the first step in prophylaxis is to identify those who are at high risk of VTE, several risk assessment models have been developed to identify these patients and provide appropriate prophylaxis. In our study, the institutional guideline in a tertiary educational hospital is the Caprini score (2006), a comparison was conducted between the institutional guideline and the American College of Chest Physicians guideline (ACCP ninth edition [ACCP-9]) in terms of the degree of agreement of the actual prophylaxis with the institutional guideline and the ACCP-9 and the differences in risk levels. The concordance with the ACCP-9 guideline was higher than with the institutional guideline, specifically in those patients receiving prophylaxis, and there was an overestimation of the risk levels in the institutional guideline, especially in medical patients. The replacement of the existing Caprini-2006 with the ACCP-9 is prudent, since it agrees with the physicians' clinical judgment and may result in reduced use of pharmacologic prophylaxis which could lead to lower costs and fewer adverse effects.
© The Author(s) 2015.

Entities:  

Keywords:  American College of Chest Physicians (ACCP); Caprini score; prophylaxis; risk assessment model; venous thromboembolism

Mesh:

Year:  2015        PMID: 25753966     DOI: 10.1177/1076029615575344

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  Evaluation of venous thromboembolism prophylaxis in a major hospital in a developing country.

Authors:  Lubna Gharaibeh; Hanan Sartawi; Diana Ayyad; Tareq Juma; Kamal Albassoumi; Enas Ismail
Journal:  Int J Clin Pharm       Date:  2017-06-16

2.  Risk of Venous Thromboembolism in Patients With Keratinocyte Carcinoma.

Authors:  Shannon F Rudy; Kevin Li; Sami P Moubayed; Sam P Most
Journal:  JAMA Facial Plast Surg       Date:  2018-12-01       Impact factor: 4.611

3.  Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms.

Authors:  Xiaolan Chen; Lei Pan; Hui Deng; Jingyuan Zhang; Xinjie Tong; He Huang; Min Zhang; Jianlin He; Joseph A Caprini; Yong Wang
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-09       Impact factor: 2.389

4.  Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.

Authors:  Hao-Yang Wang; Liu Wang; Ze-Yu Luo; Duan Wang; Xin Tang; Zong-Ke Zhou; Fu-Xing Pei
Journal:  BMC Musculoskelet Disord       Date:  2019-10-25       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.